A detailed history of Nikko Asset Management Americas, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 6,373,212 shares of TXG stock, worth $89.5 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares
6,373,212
Previous 6,148,252 3.66%
Holding current value
$89.5 Million
Previous $120 Million 20.34%
% of portfolio
1.67%
Previous 1.4%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$15.71 - $23.49 $3.53 Million - $5.28 Million
224,960 Added 3.66%
6,373,212 $144 Million
Q2 2024

Aug 09, 2024

BUY
$19.45 - $37.37 $49.1 Million - $94.4 Million
2,526,474 Added 69.76%
6,148,252 $120 Million
Q1 2024

May 02, 2024

BUY
$36.08 - $54.3 $48.3 Million - $72.7 Million
1,338,248 Added 58.6%
3,621,778 $136 Million
Q4 2023

Feb 08, 2024

BUY
$34.32 - $57.55 $19.4 Million - $32.5 Million
565,059 Added 32.88%
2,283,530 $128 Million
Q3 2023

Nov 09, 2023

SELL
$40.86 - $62.98 $1.93 Million - $2.97 Million
-47,163 Reduced 2.67%
1,718,471 $70.9 Million
Q2 2023

Aug 14, 2023

SELL
$50.96 - $58.72 $13 Million - $15 Million
-255,435 Reduced 12.64%
1,765,634 $98.6 Million
Q1 2023

May 03, 2023

SELL
$35.33 - $55.79 $5.54 Million - $8.75 Million
-156,919 Reduced 7.2%
2,021,069 $113 Million
Q4 2022

Feb 13, 2023

SELL
$24.4 - $41.3 $714,188 - $1.21 Million
-29,270 Reduced 1.33%
2,177,988 $79.4 Million
Q3 2022

Nov 14, 2022

BUY
$28.48 - $52.59 $22.6 Million - $41.7 Million
793,419 Added 56.12%
2,207,258 $61.1 Million
Q2 2022

Aug 04, 2022

SELL
$36.95 - $82.41 $662,661 - $1.48 Million
-17,934 Reduced 1.25%
1,413,839 $56.6 Million
Q1 2022

May 06, 2022

BUY
$55.7 - $145.79 $10.2 Million - $26.8 Million
183,813 Added 14.73%
1,431,773 $109 Million
Q4 2021

Feb 08, 2022

SELL
$135.05 - $182.59 $11.6 Million - $15.6 Million
-85,584 Reduced 6.42%
1,247,960 $166 Million
Q3 2021

Nov 09, 2021

SELL
$145.58 - $192.14 $30.3 Million - $40 Million
-208,044 Reduced 13.5%
1,333,544 $192 Million
Q2 2021

Aug 09, 2021

BUY
$134.22 - $202.37 $66.9 Million - $101 Million
498,675 Added 47.82%
1,541,588 $299 Million
Q1 2021

May 03, 2021

BUY
$140.25 - $196.86 $130 Million - $182 Million
924,534 Added 780.99%
1,042,913 $189 Million
Q4 2020

Feb 11, 2021

BUY
$126.47 - $163.7 $2.04 Million - $2.64 Million
16,111 Added 15.75%
118,379 $16.8 Million
Q3 2020

Nov 02, 2020

SELL
$87.44 - $125.0 $9.09 Million - $13 Million
-103,945 Reduced 50.41%
102,268 $12.2 Million
Q2 2020

Aug 07, 2020

BUY
$58.39 - $89.31 $12 Million - $18.4 Million
206,213 New
206,213 $17.8 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.33B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.